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It is my greatest pleasure to serve as the guest editor of the special issue of Neurochemical Research dedicated to Professor Graham L. Collingridge. While Graham's immense contributions to neuroscience is wide ranging, he is probably best known for the seminal discovery that longterm potentiation (LTP) in area CA1 of the hippocampus is mediated by the N-methyl-d-aspartate (NMDA) subtype of ionotropic glutamate receptors. LTP is a form of synaptic plasticity, which underlies learning and memory. This pioneering research heralded the beginning of studies in the neuropharmacology and cellular mechanisms of synaptic plasticity, a field in which Graham is internationally recognized as a leader. The papers in this special issue of Neurochemical Research were contributed by Graham's longstanding friends and collaborators. The topics of the original studies and review articles are relevant to Graham's research interests: mechanisms of synaptic plasticity in health and disease, in particular, understanding synaptic plasticity in molecular terms and how pathological alterations in these processes may lead to major brain disorders, such as Alzheimer's disease and epilepsy.
Graham was educated at George Spicer Primary School and Enfield Grammar School in Enfield, North London, England. He studied pharmacology at the University of Bristol. As a PhD student, Graham studied the effect of tetanus toxin on GABA-mediated synaptic inhibition in the rat substantia nigra at the School of Pharmacy, University College London. He was a postdoctoral fellow in the Department of Physiology at the University of British Columbia Graham's career was fundamentally defined by two major discoveries. The discovery of LTP [1] and the identification of l-glutamate receptor subtypes, such as NMDA receptors, using selective agonists (e.g. NMDA, [9] ) and antagonists (e.g. d-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5), [5] ). The development of new pharmacological tools enabled him to identify a role for the NMDA receptor in the process of LTP. As a postdoc in Vancouver, Graham observed that when he blocked the activity of the NMDA receptor with an antagonist such as D-AP5, it prevented the induction of LTP, suggesting that this was the trigger mechanism for this process [3] . His work has revealed multiple aspects of NMDA receptor function and uncovered unexpected complexity in the mechanisms of LTP [8] . Graham's early work is reviewed in this issue by his collaborators [6] . His subsequent studies dissected regulatory mechanisms and intracellular signalling pathways that are relevant to learning, memory and neurodegeneration [4] . One fundamental question was how α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors are altered at synapses following LTP induction. The notion that these receptors are rapidly moved into and out of synaptic membranes had profound implications for our understanding of the mechanisms of LTP and long-term depression [2] . More recently, Graham and his collaborators showed that calcium-permeable AMPA receptors can also trigger synaptic plasticity at hippocampal CA1 synapses [7] .
Graham's contributions to neuroscience is recognized by numerous prestigious awards and fellowships. Together with all the other contributors to this special issue in your honor, I wish you all the best for the future. We look forward with great anticipation to the next scientific discovery that you will make in the coming years.
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